$NWBO @DCarnival46

#CancerMoonshot today will not only be about glioblastoma, but about the horrible DIPG (diffuse intrinsic pontine glioma) occuring in children and young adults.

You know who got their PIP plan approved last year by the MHRA in the UK? Image
You know who ANNOUNCED a new center of cancer excellence in Sutton in the UK two months ago, 130 miles from Sawston, focusing on DIPG? Image
You know who donated 2.5 million pounds to the center and that Hugh Adams works for them and have helped NWBO meeting british politicians and he wrote the "Pathway to a Cure" report, where politicians urges MHRA and NICE to get DCVax-L to patients? Image
SAME DAY MHRA announced this

"This new funding will accelerate the delivery of cutting-edge treatments like cancer vaccines" Image
One week later the MHRA announced this. Image
The new Quarterly SEC filing says

"We plan to work on preparations for Phase II trials of DCVax-Direct as resources permit."

You know NWBO already had planned DCVax-Direct trials in 2019 targeting DIPG?

nwbio.com/wp-content/upl… Image
Just saying.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with 🇩🇰 The Danish Dude 🇬🇱

🇩🇰 The Danish Dude 🇬🇱 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @FlemmingBruce

May 8
Murcidencel's Global Recognition & NHS High Cost Drug List

MILESTONE Image
1/18

Murcidencel, the WHO-assigned INN for DCVax-L, has achieved major regulatory milestones:

Included in WHO INN Proposed List 128 (2023)

Advanced to WHO INN Recommended List 90 (2023)

Confirming global recognition for NWBO's DC vaccine.

NHS: April 1st.
NICE: April 2nd. Image
2/15

The WHO INN Recommended List 90 explicitly describes Murcidencel as:

Autologous DCs derived from glioblastoma patients

Pulsed with tumor lysate

Grown with GM-CSF & IL-4

This matches DCVax-L’s manufacturing process perfectly.
Read 19 tweets
May 4
$NWBO

Czech Trial: The Missing Link

With the help of @d_stock07734's due diligence, it seems like we are able to uncover what must have been quite a challenge at that time for Masaryk University.

The manufactoring of the dendritic cell vaccine for the trial. Image
Please follow @d_stock07734 for additional due diligence regarding the Czech Trial results and other possible links.

🙏

1/

In 2014, Masaryk University launched a pediatric trial using a dendritic cell vaccine called MyDendrix to treat children with metastatic/refractory tumors.

The methods looked strikingly familiar to NWBO’s DCVax-L platform.

But how?
Read 21 tweets
May 3
$NWBO

Allow me to entertain a hypothesis, that is probable "far out", but which I somehow still find believable, knowing Linda Powers setup several dormant companies in 2014, obviously trying to predict a few chess board moves over the last decade.

Let's say she did that.
1/

Something extraordinary may have just come together for NWBO - and many missed it.

A Czech trial, once unrelated, now bears the name Murcidencel - the official WHO name for NWBO’s DCVax-L.

Coincidence?

ChatGPT and Perplexity says otherwise.
2/

In 2022, the WHO approved Murcidencel as the INN for NWBO’s DCVax-L.

This isn’t a marketing term - it’s an internationally protected name that defines the therapy's composition:

autologous dendritic cells, tumor lysate, matured with GM-CSF and IL-4.
Read 18 tweets
May 1
$NWBO

1/

Laura Posner (Cohen Milstein) & Columbia law prof Joshua Mitts filed a powerful amicus brief in Slack v. Pirani, arguing that modern tech makes it possible to trace stock origins—a key issue in securities fraud.

Source:

cohenmilstein.com/laura-posner-d…Image
2/

In the case, the Supreme Court ruled that if you sue under Section 11 of the Securities Act, you must prove your shares came from the registration statement you’re challenging.

That’s called traceability
3/

Critics said this would block investors from suing, especially in direct listings where shares are mixed.

But Posner & Mitts argued: with today’s digital trading records, we can trace shares.
Read 11 tweets
May 1
$NWBO

1.

The Czechia 🇨🇿 trial has just been updated 20.00 local time. It’s a public holiday in many countries and after business hours in Europe,

That’s the 4th consecutive update in 4 days.

But why now, and from where? Image
2/

First: this is not a recruiting trial.

It ended in 2024, is marked “Not Recruiting,” and was migrated into CTIS for administrative purposes.

Yet it’s getting multiple backend updates — and the latest occurred at 8PM local time on a national holiday.
3/
CTIS is managed by the European Medicines Agency (EMA), not Czech authorities.

Updates are submitted by sponsors or authorized users through the central EMA portal

That means:

• The update did NOT need to originate in Czechia

• It’s almost certainly manual, not automated
Read 8 tweets
Apr 30
$NWBO

Read!

Best news this week. 👍🏻 Image
Image
Image
Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(